Trial Outcomes & Findings for NICU Oxygen Control Study (NCT NCT04269161)

NCT ID: NCT04269161

Last Updated: 2025-07-04

Results Overview

Mean in elapsed time needed to re- establish SpO2 within the desired range after an alarm. The alarms and alarm times are recorded directly from the bedside monitor and the responses are measured directly in terms of the blend valve position and SpO2 response measured by the pulse oximeter.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

48 participants

Primary outcome timeframe

Twenty-four study periods consisting of 6-hour manual study periods and 6-hour automatic study periods over six days for each of the subjects in the analysis.

Results posted on

2025-07-04

Participant Flow

Participant milestones

Participant milestones
Measure
Crossover Sequence 1
In this arm, an automatic oxygen control device will be used to make adjustments to the blend of oxygen and air supplied to the subject for the first six hours. In this arm, a nurse will manually make adjustments to the blend of oxygen and air supplied to the subject for the second six hours. The study continues in an automatic and manual repeating pattern for six days. Automatic control of inspired oxygen: A device will be used to automatically adjust the blend of oxygen and air with the ability to return to manual control as needed.
Crossover Sequence 2
In this arm, a nurse will manually make adjustments to the blend of oxygen and air supplied to the subject as in the standard of care for the first six hours. In this arm, an automatic oxygen control device will be used to make adjustments to the blend of oxygen and air supplied to the subject for the second six hours. The study continues in a manual and automatic repeating pattern for six days. Automatic control of inspired oxygen: A device will be used to automatically adjust the blend of oxygen and air with the ability to return to manual control as needed.
Overall Study
STARTED
24
24
Overall Study
COMPLETED
19
20
Overall Study
NOT COMPLETED
5
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Crossover Sequence 1
In this arm, an automatic oxygen control device will be used to make adjustments to the blend of oxygen and air supplied to the subject for the first six hours. In this arm, a nurse will manually make adjustments to the blend of oxygen and air supplied to the subject for the second six hours. The study continues in an automatic and manual repeating pattern for six days. Automatic control of inspired oxygen: A device will be used to automatically adjust the blend of oxygen and air with the ability to return to manual control as needed.
Crossover Sequence 2
In this arm, a nurse will manually make adjustments to the blend of oxygen and air supplied to the subject as in the standard of care for the first six hours. In this arm, an automatic oxygen control device will be used to make adjustments to the blend of oxygen and air supplied to the subject for the second six hours. The study continues in a manual and automatic repeating pattern for six days. Automatic control of inspired oxygen: A device will be used to automatically adjust the blend of oxygen and air with the ability to return to manual control as needed.
Overall Study
Change of modality and no longer eligible
3
3
Overall Study
Required procedure outside of NICU
1
0
Overall Study
Equipment issue
1
1

Baseline Characteristics

NICU Oxygen Control Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Crossover Sequence 1 and 2, Automatic, Manual and Manual, Automatic
n=39 Participants
This group is comprised of Crossover Sequence 1 and Crossover Sequence 2 with all participants that completed six days in the study. The automatic oxygen control device or the nurse made adjustments to the blend of oxygen and air supplied to the participant for alternating blocks of six hours. The study continues in an automatic and manual repeating pattern for six days.
Age, Continuous
27.428 weeks
STANDARD_DEVIATION 2.448 • n=5 Participants
Sex: Female, Male
Female
16 Participants
n=5 Participants
Sex: Female, Male
Male
23 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
7 Participants
n=5 Participants
Race (NIH/OMB)
White
30 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Crossover Sequence 1 or 2
Sequence 1 - Automatic, Manual
19 Participants
n=5 Participants
Crossover Sequence 1 or 2
Sequence 2 - Manual, Automatic
20 Participants
n=5 Participants
Modality
High-Flow Nasal Cannula (HFNC)
22 Participants
n=5 Participants
Modality
Bubble CPAP (BCPAP)
17 Participants
n=5 Participants
Weight at start of study
1702.205 grams
STANDARD_DEVIATION 531.817 • n=5 Participants
Bed type
Isolette
32 Participants
n=5 Participants
Bed type
Open Crib
7 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Twenty-four study periods consisting of 6-hour manual study periods and 6-hour automatic study periods over six days for each of the subjects in the analysis.

Population: All participants that completed six days of the crossover study period were analyzed.

Mean in elapsed time needed to re- establish SpO2 within the desired range after an alarm. The alarms and alarm times are recorded directly from the bedside monitor and the responses are measured directly in terms of the blend valve position and SpO2 response measured by the pulse oximeter.

Outcome measures

Outcome measures
Measure
Manual Mode (Nurse)
n=39 Participants
Nurse adjusts the blend of oxygen and air manually for six hour periods (no automatic oxygen control by the device).
Automatic Mode (Device)
n=39 Participants
An investigational device used to automatically adjust the blend of oxygen and air for six-hour periods with the ability to return to manual control as needed.
Elapsed Time to Respond to SpO2 Alarm
51.408 seconds
Standard Deviation 66.168
41.523 seconds
Standard Deviation 30.771

SECONDARY outcome

Timeframe: Twelve 6-hour manual study periods and 6-hour automatic study periods over six days for each of the subjects in the analysis.

Population: All participants who completed six days in the study were included in the analysis.

For each 6-hour time block, we calculate the proportion of time the patient stays within the prescribed SpO2 range. The proportion of time that the SpO2 is within the prescribed range is computed using an area-under-the-curve approach for data taken during automatic control by the experimental device and manual control by the nurse.

Outcome measures

Outcome measures
Measure
Manual Mode (Nurse)
n=39 Participants
Nurse adjusts the blend of oxygen and air manually for six hour periods (no automatic oxygen control by the device).
Automatic Mode (Device)
n=39 Participants
An investigational device used to automatically adjust the blend of oxygen and air for six-hour periods with the ability to return to manual control as needed.
Proportion of Time SpO2 is Within the Prescribed Range in a Six-hour Time Block
0.676 proportion of time
Standard Deviation 0.214
0.695 proportion of time
Standard Deviation 0.224

Adverse Events

Manual Mode (Nurse)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Automatic Mode (Device)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Roger Fales

University of Missouri

Phone: 5738841564

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place